Patrick Fabbio's Insider Trades & SAST Disclosures
Patrick Fabbio's most recent trade in BeyondSpring Inc was a trade of 23,793 Stock Options (right to buy) done . Disclosure was reported to the exchange on April 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patrick Fabbio.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BeyondSpring Inc | Patrick Fabbio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2025 | 23,793 | 23,793 | - | - | Stock Options (right to buy) | |
| Protara Therapeutics Inc | Patrick Fabbio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Patrick Fabbio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 23,500 | 45,500 (0%) | 0% | 0 | Common Stock | |
| Protara Therapeutics Inc | Patrick Fabbio | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 21 Jan 2025 | 3,061 | 18,939 (0%) | 0% | 4.8 | 14,570 | Common Stock |
| Protara Therapeutics Inc | Patrick Fabbio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 131,000 | 131,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Fabbio Patrick | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 22,000 | 22,000 (0%) | 0% | 0 | Common Stock | |
| Protara Therapeutics Inc | Patrick Fabbio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Rafael Holdings Inc - Ordi... | Patrick Fabbio | CFO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.76 per share. | 21 Dec 2022 | 27,928 | 335,175 (2%) | 0% | 1.8 | 49,153 | Class B Common Stock, par value $.01 per share |
| Rafael Holdings Inc - Ordi... | Patrick Fabbio | CFO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 363,103 | 363,103 (2%) | 2% | 0 | Class B Common Stock, par value $.01 per share | |
| Rafael Holdings Inc - Ordi... | Patrick Fabbio | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2021 | 105,602 | 105,602 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges